Disease | hyperthyroidism |
Phenotype | C0022661|chronic kidney disease |
Sentences | 2 |
PubMedID- 22305461 | Cin is effective in clinical setting and it has been approved for the treatment of secondary hyperthyroidism in patients with chronic kidney disease placed on dialysis [3], and for the treatment of elevated calcium levels in patients with parathyroid carcinoma [4]. |
PubMedID- 20452793 | After intravenous administration of (51)cr-edta, seven blood samples were obtained in 46 cats (19 euthyroid and 27 hyperthyroid cats, none with previously diagnosed chronic kidney disease (ckd)). |
Page: 1